Cytokinetics | Spese Di Vendita E Di Amministrazione



Selling And Administration Expenses Cambiamento Data
Acadia Pharmaceuticals USD 130.08M 3.21M 2024-12
Amgen USD 1.88B 253M 2024-12
Bayer EUR 4.34B 610M 2024-12
Biogen USD 677.3M 99.6M 2024-12
Bristol-Myers Squibb USD 1.58B 521M 2025-03
Cytokinetics USD 62.34M 5.69M 2024-12
Eisai JPY 104.52B 7.1B 2024-12
Eli Lilly USD 2.36B 62.3M 2025-03
Exelixis USD 134.33M 22.53M 2025-01
Geron USD 43.37M 7.49M 2024-12
Halozyme Therapeutics USD 42.25M 1.01M 2024-12
Ionis Pharmaceuticals USD 76M 12.08M 2025-03
Ligand Pharmaceuticals USD 25.6M 1.13M 2024-12
Merck USD 2.53B 319M 2025-03
Novartis USD 3.5B 368M 2024-12
Pfizer USD 3.01B 1.27B 2025-03
Regeneron Pharmaceuticals USD 633M 159.2M 2025-03
Roche Holding CHF 3.61B 381M 2024-12
Sanofi EUR 2.22B 980M 2025-03



Cytokinetics Spese Di Vendita E Di Amministrazione - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.